CTRI/2020/12/030006Not yet recruitingPhase 4
Evaluation of efficacy and safety of Constipation Formulation in the management of Constipation in Children: A prospective, randomised, double-blind, single center, placebo-controlled, interventional study
Trial Snapshot
- Phase
- Phase 4
- Status
- Not yet recruiting
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1. Male and female children aged >=3 to <=16 years.
- •2. Duration of constipation more than 4 weeks.
- •3. Presence of >=2 of the following:
- •a. defecation frequency <=2 times per week
- •b. faecal incontinence >=1 time per week
- •c. history of excessive stool retention
- •d. history of painful or hard bowel movements
- •e. presence of a large mass in the rectum or on per abdomen examination
- •f. history of large-diameter stools that may obstruct the toilet (if information available)
- •4. Children willing to provide informed assent if applicable.
- •5. Childâ??s parent/guardian/legally acceptable representative willing to provide informed written consent.
Exclusion Criteria
- •1. Presence of other organic disorders which might be cause of constipation.
- •2. Children suffering from irritable bowel syndrome
- •3. Children with hormonal diseases
- •4. Children who have received other treatments for constipation in the past 48 hours.
- •5. Children who are planned to be treated through disimpaction.
- •6. Current or past history of a serious illness including, seizures, major psychiatric illness, structural brain disease, liver or kidney failure, organ transplantation, rheumatoid arthritis, uncontrolled hypertension, uncontrolled diabetes or malignancy, cardiovascular event in the last three months.
- •7. Allergy or sensitivity to any of the ingredients in the study treatment.
- •8. Subjects who have participated in other clinical studies during the past 3 months or subjects who intend to participate in other clinical studies parallelly.
- •9. Subjects with any other illness or health condition which in the opinion/medical judgement of the study investigator makes the subject ineligible to participate in the study.
Investigators
Similar Trials
Recruiting
Phase 3
Evaluation of treatment of constipation induced infectioConstipationIRCT20201226049834N1Iran University of Medical Sciences120
Recruiting
Phase 1
The effect of the therapy of 'combination three methods progression' in patients with neurogenic bowel dysfunction (constipated type): study protocol for a randomized controlled trialITMCTR2100004571Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Completed
Phase 3
Evaluation of treatment of chronic constipation using combination of Rosa damascene and brown sugar in comparison with polyethylene glycol in children over 12 months oldConstipation.K59.0constipationIRCT20090908002434N8Shiraz University of Medical Sciences100
Not yet recruiting
Phase 2
Comparing The Effects Of Physiotherapy Treatment Versus Drug Therapy For Constipation In Children With Autism Spectrum DisorderCTRI/2024/08/072280Esha Uday Kamat
Completed
Phase 2
Examination of improvement of constipation by Tanden breathingconstipationsJPRN-UMIN000035662Okayama University21
